Simplex Trading’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.07K | Sell |
3,100
-19,600
| -86% | -$62.2K | ﹤0.01% | 7646 |
|
|
2025
Q4 | $90.8K | Buy |
22,700
+11,900
| +110% | +$66.2K | ﹤0.01% | 5090 |
|
|
2025
Q3 | $91K | Sell |
10,800
-11,200
| -51% | -$109K | ﹤0.01% | 5851 |
|
|
2025
Q2 | $247K | Buy |
22,000
+20,200
| +1,122% | +$186K | ﹤0.01% | 4275 |
|
|
2025
Q1 | $17K | Sell |
1,800
-55,800
| -97% | -$564K | ﹤0.01% | 6702 |
|
|
2024
Q4 | $648K | Sell |
57,600
-113,800
| -66% | -$2M | ﹤0.01% | 3276 |
|
|
2024
Q3 | $4.85M | Buy |
171,400
+119,800
| +232% | +$3.09M | ﹤0.01% | 1507 |
|
|
2024
Q2 | $986K | Buy |
51,600
+28,100
| +120% | +$718K | ﹤0.01% | 2924 |
|
|
2024
Q1 | $770K | Sell |
23,500
-100,800
| -81% | -$3.22M | ﹤0.01% | 3397 |
|
|
2023
Q4 | $4.11M | Buy |
124,300
+118,600
| +2,081% | +$3.36M | ﹤0.01% | 1730 |
|
|
2023
Q3 | $155K | Buy |
5,700
+600
| +12% | +$16.7K | ﹤0.01% | 4632 |
|
|
2023
Q2 | $154K | Buy |
5,100
+3,700
| +264% | +$120K | ﹤0.01% | 4596 |
|
|
2023
Q1 | $45K | Sell |
1,400
-1,400
| -50% | -$44.3K | ﹤0.01% | 6034 |
|
|
2022
Q4 | $78K | Sell |
2,800
-4,300
| -61% | -$123K | ﹤0.01% | 5364 |
|
|
2022
Q3 | $255K | Buy |
7,100
+4,900
| +223% | +$173K | ﹤0.01% | 4284 |
|
|
2022
Q2 | $67K | Buy |
2,200
+2,100
| +2,100% | +$61.2K | ﹤0.01% | 6097 |
|
|
2022
Q1 | $3K | Sell |
100
-7,000
| -99% | -$183K | ﹤0.01% | 9680 |
|
|
2021
Q4 | $196K | Buy |
7,100
+200
| +3% | +$5.74K | ﹤0.01% | 5226 |
|
|
2021
Q3 | $145K | Hold |
6,900
| – | – | ﹤0.01% | 6086 |
|
|
2021
Q2 | $145K | Buy |
+6,900
| New | +$138K | ﹤0.01% | 6185 |
|
|
2021
Q1 | – | Sell |
-49
| Closed | -$78K | – | 9121 |
|
|
2020
Q4 | $78K | Buy |
49
+44
| +880% | +$582 | ﹤0.01% | 5684 |
|
|
2020
Q3 | $6K | Sell |
5
-198
| -98% | -$2.33K | ﹤0.01% | 7020 |
|
|
2020
Q2 | $144K | Buy |
203
+192
| +1,745% | +$1.29K | ﹤0.01% | 4390 |
|
|
2020
Q1 | $5K | Sell |
11
-3
| -21% | -$27 | ﹤0.01% | 6825 |
|
|
2019
Q4 | $12K | Buy |
14
+12
| +600% | +$97 | ﹤0.01% | 6280 |
|
|
2019
Q3 | $1K | Sell |
2
-47
| -96% | -$337 | ﹤0.01% | 7028 |
|
|
2019
Q2 | $38K | Sell |
49
-179
| -79% | -$2.12K | ﹤0.01% | 5083 |
|
|
2019
Q1 | $286K | Buy |
+228
| New | +$3.61K | ﹤0.01% | 3240 |
|
|
2018
Q4 | – | Sell |
-107
| Closed | -$303K | – | 7204 |
|
|
2018
Q3 | $303K | Buy |
107
+78
| +269% | +$1.86K | ﹤0.01% | 3170 |
|
|
2018
Q2 | $61K | Sell |
29
-36
| -55% | -$681 | ﹤0.01% | 4831 |
|
|
2018
Q1 | $7K | Buy |
65
+42
| +183% | +$601 | ﹤0.01% | 4323 |
|
|
2017
Q4 | $3K | Sell |
23
-598
| -96% | -$8.43K | ﹤0.01% | 4876 |
|
|
2017
Q3 | $269K | Sell |
621
-39
| -6% | -$804 | 0.01% | 1013 |
|
|
2017
Q2 | $109K | Sell |
660
-94
| -12% | -$2.26K | ﹤0.01% | 1680 |
|
|
2017
Q1 | $15K | Buy |
754
+501
| +198% | +$9.62K | ﹤0.01% | 3552 |
|
|
2016
Q4 | $65K | Buy |
+253
| New | +$4.99K | ﹤0.01% | 1896 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Simplex Trading's EVH Position: Q1 2026 in Review
Simplex Trading sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 47,159 shares — an estimated $150K sold.
Simplex Trading first reported a position in EVH in Q3 2016 and held it in 30 quarters. The position peaked at $2.72M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Simplex Trading reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 47,159 Evolent Health shares in Q1 2026, an estimated $150K.
- Simplex Trading first reported a position in Evolent Health in Q3 2016 and held it in 30 quarters.
- Simplex Trading's Evolent Health position peaked at $2.72M in Q4 2023.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.